Nuwellis Amends Offering to Raise $5M via Shares and Warrants, Facing 1255% Potential Dilution
Summary
Nuwellis, a financially distressed nano-cap company, amended its offering to raise $5.0 million through a highly dilutive sale of shares and multiple warrants, including those with reset and zero-cash exercise features, and plans to reprice existing warrants.
Key Events
-
Amended Public Offering
Nuwellis filed an S-1/A to raise approximately $5.0 million in gross proceeds through a 'reasonable best efforts' offering of up to 6,578,948 units, each consisting of common stock (or pre-funded warrant) and accompanying Series C and Series D common warrants. This is a reduction from a previously finalized $9.4 million offering.
-
Premium Offering Price with Significant Dilution
The assumed offering price is $0.76 per unit, a premium to the current stock price of $0.4336. However, the offering is highly dilutive, with the potential to issue up to 33,092,108 shares from all warrants, representing over 1255% dilution to current outstanding shares.
-
Unfavorable Warrant Terms
Series C warrants include a one-time exercise price reset feature, and Series D warrants have a 'zero cash exercise' option, meaning the company will not receive additional funds upon their exercise. Both terms are highly unfavorable for existing shareholders.
-
Repricing of Existing Warrants
The company also plans a concurrent private transaction to reduce the exercise price of up to 3,284,788 outstanding warrants to the public offering price of $0.76, subject to stockholder approval, further increasing potential dilution.
Analysis
Nuwellis, a nano-cap company facing a 'going concern' warning and Nasdaq delisting threats, filed an amendment to its S-1 registration statement to raise approximately $5.0 million in gross proceeds. This is a material change from its previous S-1/A filing on May 29, 2026, which finalized a $9.4 million offering. The offering consists of up to 6,578,948 units, each comprising a share of common stock (or pre-funded warrant) and accompanying Series C and Series D common warrants, priced at an assumed $0.76 per unit. While this unit price is a premium to the current stock price of $0.4336, the offering is highly dilutive. The Series C warrants include a one-time exercise price reset feature, and the Series D warrants have a zero-cash exercise option, meaning no additional funds will be received by the company upon their exercise. Additionally, the company plans to reduce the exercise price of up to 3,284,788 outstanding warrants to the offering price, subject to stockholder approval. If all warrants associated with this offering are exercised, it could result in a potential dilution of over 1255% to existing shareholders. This capital raise is critical for the company's operations through the end of fiscal year 2026, but comes with substantial dilution.
At the time of this filing, NUWE was trading at $0.43 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.2M. The 52-week trading range was $0.43 to $34.02. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.